[VRTX] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
03-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 44.87%
YoY- 79.04%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 858,435 640,799 714,718 398,080 138,509 118,451 328,368 17.36%
PBT 320,165 214,642 253,533 -30,617 -198,405 -231,654 -442,940 -
Tax 51,534 -12,659 3,985 5,485 299 803 -130,313 -
NP 268,631 210,263 247,756 -41,631 -198,606 -232,457 -308,016 -
Tax Rate -16.10% 5.90% -1.57% - - - - -
Total Cost 589,804 430,536 466,962 439,711 337,115 350,908 636,384 -1.25%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 31.29 32.81 34.66 -10.46 -143.39 -196.25 -93.80 -
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS 1.05 0.83 1.01 -0.17 -0.83 -1.00 -1.43 -
EPS Diluted 1.03 0.81 0.99 -0.17 -0.83 -1.00 -1.43 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.